Patents by Inventor Devanshi Shanghavi

Devanshi Shanghavi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CNP Therapy
    Publication number: 20250032576
    Abstract: The present disclosure relates, in general, to measures of efficacy in patients receiving C-type natriuretic peptide (CNP) therapy to treat a skeletal dysplasia, short stature or bone-related disorders.
    Type: Application
    Filed: December 7, 2022
    Publication date: January 30, 2025
    Inventors: George Jeha, Christopher Bauer, Sergio Covarrubias, Devanshi Shanghavi, Yu-Shan Tseng, Jonathan Day, Elena Fisheleva
  • TARGETED IMMUNOTOLERANCE WITH A PD-1 AGONIST
    Publication number: 20250002582
    Abstract: Methods and polypeptides for conferring site-specific or local immune privilege.
    Type: Application
    Filed: August 29, 2024
    Publication date: January 2, 2025
    Applicant: Pandion Operations, Inc.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Salvatore Alioto, Lindsay J. Edwards, Jacob Glanville, David Maurer, Sarah Ives, Sawsan Youssef, Devanshi Shanghavi, Lauren Schwimmer
  • TARGETED IMMUNOTOLERANCE WITH A PD-1 AGONIST
    Publication number: 20210206856
    Abstract: Methods and polypeptides for conferring site-specific or local immune privilege.
    Type: Application
    Filed: August 19, 2020
    Publication date: July 8, 2021
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Salvatore Alioto, Lindsay J. Edwards, Jacob Glanville, David Maurer, Sarah Ives, Sawsan Youssef, Devanshi Shanghavi, Lauren Schwimmer